Akero Therapeutics
AKRO
AKRO
103 hedge funds and large institutions have $499M invested in Akero Therapeutics in 2022 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 35 increasing their positions, 25 reducing their positions, and 8 closing their positions.
Holders
103
Holders Change
+6
Holders Change %
+6.19%
% of All Funds
1.63%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
14
Increased
35
Reduced
25
Closed
8
Calls
$1K
Puts
$460K
Net Calls
-$459K
Net Calls Change
+$612K
Top Buyers
Top Sellers
1 |
1
T. Rowe Price Associates
Baltimore,
Maryland
|
$6.46M |
2 |
2
Goldman Sachs
New York
|
$15.5M |
3 |
CS
3
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
$0 |
4 |
4
Alkeon Capital Management
New York
|
$34.3M |
5 |
5
BlackRock
New York
|
$26.9M |